NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/14/2018
Back to search
Official data from USPTO
GLYCOBIEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
09/14/2018
Trademark type
Word
Nice classes
5
Filing date
06/08/2006
Registration date
07/22/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/14/2018
Last transaction
09/14/2018
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Scarborough, Ontario, CA
Examiner
FINE, STEVEN
Law office
M10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Orx Pharmaceutical Corp.
Representatives
Aleksandar Nikolic A Nikolic Law
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations used to regulate blood sugar levels to treat diabetes; pharmaceutical preparations to lower blood sugar levels; pharmaceutical preparations to control insulin levels for the treatment of polycystic ovary syndrome; metformin
Publications
History of USPTO decisions and trademark events.
28 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/14/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/14/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/15/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
08/03/2018
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
02/23/2016
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
02/23/2016
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
07/31/2014
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
07/31/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/31/2014
ES8R
TEAS SECTION 8 RECEIVED
07/21/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
07/22/2008
PUBO
PUBLISHED FOR OPPOSITION
05/06/2008
NPUB
NOTICE OF PUBLICATION
04/16/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/29/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/28/2008
ACEC
AMENDMENT FROM APPLICANT ENTERED
02/29/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/29/2008
ALIE
ASSIGNED TO LIE
02/28/2008
PAPER RECEIVED
01/24/2008
CNSI
INQUIRY AS TO SUSPENSION MAILED
07/30/2007
CNSI
SUSPENSION INQUIRY WRITTEN
07/30/2007
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
05/22/2007
ALIE
ASSIGNED TO LIE
05/22/2007
CNSL
LETTER OF SUSPENSION MAILED
11/15/2006
CNSL
SUSPENSION LETTER WRITTEN
11/14/2006
DOCK
ASSIGNED TO EXAMINER
11/09/2006
NWAP
NEW APPLICATION ENTERED
06/14/2006
Continuous trademark protection
Get notified about every new filing that threatens GLYCOBIEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.